<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15(5)</volume><submitter>Sarlak S</submitter><funding>H2020 TheraLymph</funding><funding>Fondation Estée Lauder</funding><funding>Fédération Claude Lalanne</funding><funding>Canceropôle PACA</funding><funding>CNRS, Université Côte d'Azur</funding><funding>Pink Ribbon</funding><funding>Ligue Nationale contre le Cancer (Equipe Labellisée 2019)</funding><funding>ARCAGEING2023020006332</funding><funding>Met'Connect</funding><funding>Fondation ARC de la Recherche contre le Cancer Programme Labellisé 2022</funding><journal>Clinical and translational medicine</journal><pagination>e70330</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12095174</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Comparative impact of proton versus photon irradiation on triple-negative breast cancer: Role of VEGFC in tumour aggressiveness.</pubmed_title><pmcid>PMC12095174</pmcid><funding_grant_id>874708</funding_grant_id><funding_grant_id>ARCPOST-DOC2021070004080</funding_grant_id><pubmed_authors>Tsai MC</pubmed_authors><pubmed_authors>Gouraud A</pubmed_authors><pubmed_authors>Molina C</pubmed_authors><pubmed_authors>Dufies M</pubmed_authors><pubmed_authors>Sarlak S</pubmed_authors><pubmed_authors>Luciano F</pubmed_authors><pubmed_authors>Morfoisse F</pubmed_authors><pubmed_authors>Marotte D</pubmed_authors><pubmed_authors>Karaulic A</pubmed_authors><pubmed_authors>Sylvestre R</pubmed_authors><pubmed_authors>Doyen J</pubmed_authors><pubmed_authors>Garmy-Susini B</pubmed_authors><pubmed_authors>Pierantoni A</pubmed_authors><pubmed_authors>Pages G</pubmed_authors><pubmed_authors>Vidal M</pubmed_authors><pubmed_authors>Bancaud A</pubmed_authors><pubmed_authors>Sirera J</pubmed_authors><pubmed_authors>Kousteridou P</pubmed_authors><pubmed_authors>Herault J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Comparative impact of proton versus photon irradiation on triple-negative breast cancer: Role of VEGFC in tumour aggressiveness.</name><description/><dates><release>2025-01-01T00:00:00Z</release><publication>2025 May</publication><modification>2026-06-03T02:43:27.924Z</modification><creation>2026-04-23T03:10:40.84Z</creation></dates><accession>S-EPMC12095174</accession><cross_references><pubmed>40400121</pubmed><doi>10.1002/ctm2.70330</doi></cross_references></HashMap>